Consolidated Financial Results for the First Quarter of the Fiscal Year Ending February 29, 2024
[Japanese GAAP]
July 13, 2023
Company name:

Hisamitsu Pharmaceutical Co., Inc.

Stock exchange listing:Tokyo, Nagoya, Fukuoka

Securities code:

4530

URL:

https://global.hisamitsu/

Representative:

NAKATOMI Kazuhide, President & CEOContact

ISOBE Yuichi, Excective Officer, Department General Manager of Corporate Strategy Planning andBusiness Development

TEL:+81-3-5293-1704

Scheduled date of filing quarterly securities report:

July 14, 2023

Scheduled date of dividend payment:―Preparation of supplementary materials for quarterly financial results:

Yes

Holding of quarterly financial results meeting:Yes (for institutional investors and analysts, etc.)(Amounts are rounded down to the nearest millions of yen)

1. Consolidated Financial Results for the First Quarter of the Fiscal Year Ending February 29, 2024
(March 1, 2023 to May 31, 2023)(1) Consolidated Operating Results(Percentages represent year-on-year changes)
Net sales

Operating profit

Millions of yen%

Millions of yen

Profit attributable toowners of parent

Ordinary profit%

Millions of yen%

Millions of yen%Three months ended May 31, 2023

32,096

21.6

4,361

739.1

5,713

148.6

4,049

148.2

Three months ended May 31, 2022

26,393(4.9)

519(75.5)

2,298(19.5)

1,631(30.9)(Note) Comprehensive income:Three months ended May 31, 2023

6,501 millions of yen [8.1%]

Three months ended May 31, 2022

6,012 millions of yen [(1.0%)]

Profit per share

Diluted profit pershareyenyen

Three months ended May 31, 2023

52.09

52.05

Three months ended May 31, 2022

20.46

20.45

(2) Consolidated Financial Position
Total assets

Shareholders’equity ratio

Millions of yen

Millions of yen%

320,184

261,62980.9

313,917

258,408

81.6

As of May 31, 2023
As of Feb. 28, 2023
(Reference) Shareholders’ equity:

Net assets

As of May 31, 2023

259,139 millions of yen

As of Feb. 28, 2023

256,105 millions of yen

2. Dividends
Annual dividends
First quarter

Second quarter

Third quarter

Fouth quarter

Total

yen

yen

yen

yenyenYear ended Feb. 28, 2023

―

42.25

―

42.25

84.50

Year ending Feb. 29, 2024

―
42.50

―

42.50

85.00

Year ending Feb. 29, 2024
(Forecast)(Note) Revisions to the most recently announced dividends forecast:No

3. Consolidated Earnings Forecast for the Fiscal Year Ending February 29, 2024 (March 1, 2023 to February 29, 2024)(Percentages represent year-on-year changes)

Net sales
Full year

Operating profit

Millions of yen%

Millions of yen

132,300

3.1

11,800

Profit attributable toowners of parent

Ordinary profit%

1.7(Note) Revisions to the most recently announced consolidated forecast:
NoProfit pershare

Millions of yen%

Millions of yen%

yen

14,600(9.0)

10,600(9.7)

136.34*Notes(1) Changes in significant subsidiaries during the period(Chages in specified subsidiaries resulting in changes in scope of consolidation): None(2) Apprication of special accounting methods for preparation of quarterly consolidated financial statements(3) Changes in accounting policies, changes in accounting estimates, and restatement
1) Changes in accounting policies due to revision of accounting standards
2) Changes in accounting policies other than 1) above
3) Changes in accounting estimates
4) Restatement: Yes: None: None: None: None

(4) The number of shares outstanding (common stock)1) Total number of shares outstanding at the end of the period (including treasury stock)
As of May 31, 2023
85,164,895 shares
As of Feb. 28, 2023
85,164,895 shares2) Total number of treasury stock at the end of the period
As of May 31, 2023
7,420,650 shares
As of Feb. 28, 2023
7,420,560 shares
3) Average number of shares outstanding during the period
Three months ended May 31, 2023
77,744,275 shares
Three months ended May 31, 2022
79,737,560 shares*Quarterly financial results reports are not subjected to quarterly review.
*Explanation for appropriate use of financial forecasts and other special notes
Among this document, the forecasts based on the plan may changes due to uncertain factors. Therefore, the actual
operating results may differ from the company's view.
Financial settlement briefings for institutional investors and analysts will be held on July 13, 2023. Presentation materialsof financial results will be posted promptly on the company’s website after the financial settlement briefings.

Quarterly Consolidated Financial Statements(1) Quarterly Consolidated Balance sheets(Millions of yen)

Prior Fiscal Year End(As of Feb. 28, 2023)

Current First Quarter(As of May 31, 2023)

AssetsCurrent assets
Cash and deposits

122,154

122,303

Notes and accounts receivable - trade, and contract assets

40,01438,793

Securities

14,714

14,217

Merchandise and finished goods

10,33011,116562

733

Raw materials and supplies

8,030

8,199

Other

3,629

6,262

Allowance for doubtful accounts

(261)

(251)

199,174

201,375

Buildings and structures, net

13,98013,977

Other, net

29,22931,218

Total property, plant and equipment

43,20945,196

Sales rights

394

382

Other551

494

Total intangible assets

946

877

Investment securities

60,84562,513

Other

9,948

10,428Work in process

Total current assets
Non-current assets
Property, plant and equipment

Intangible assets

Investments and other assets

Allowance for doubtful accounts

(207)

(207)

Total investments and other assets

70,586

72,734

114,742

118,809

313,917

320,184

Total non-current assets
Total assets

(Millions of yen)

Prior Fiscal Year End(As of Feb. 28, 2023)

Current First Quarter(As of May 31, 2023)

Liabilities
Current liabilities
Notes and accounts payable - trade

8,351

7,368

Electronically recorded obligations - operating

6,567

6,619

Short-term loans payable

1,071

1,071

Income taxes payable

2,338

1,943

Provision for bonuses

1,340

369

Other

22,90827,623

Total current liabilities

42,57844,996

Non-current liabilities
Long-term loans payable

147

131

Net defined benefit liability

8,408

8,450

Other

4,375

4,977

Total non-current liabilities

12,931

13,55955,50958,555

Capital stock

8,473

8,473

Capital surplus

2,361

2,361

Total liabilities
Net assets
Shareholders' equity

Retained earnings

235,569

236,333

Treasury shares(27,196)(27,196)

Total shareholders' equity

219,208

219,971

17,042

18,437

Accumulated other comprehensive income
Valuation difference on available-for-sale securities
Revaluation reserve for land

3,403

3,403

Foreign currency translation adjustment

15,81916,763Remeasurements of defined benefit plans
Total accumulated other comprehensive income

631

562

36,896

39,167

Share acquisition rights

260

270

Non-controlling interests

2,042

2,220

258,408

261,629

313,917

320,184

Total net assets
Total liabilities and net assets

(2) Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statements of Income(Millions of yen)

Prior Fiscal Year
(Mar. 1, 2022 – May 31 2022)

Current Fiscal Year
(Mar. 1, 2023 – May 31 2023)

26,39332,096

Cost of sales

11,647

13,378Gross profit

14,74518,718Selling, general and administrative expenses

14,225

14,356519

4,361Interest income

52470

Dividend income

83

90

1,657

618

136

232

1,929

1,413

Net sales

Operating profit
Non-operating incomeForeign exchange gains
Other
Total non-operating income
Non-operating expenses
Interest expenses

00

Share of loss of entities accounted for using equity method

108

42

Other

41

17

Total non-operating expenses

15061

2,298

5,713

Gain on disposal of non-current assets

141－

Total extraordinary income

141－

Loss on disposal of non-current assets

41

0Total extraordinary losses

410

2,398

5,712

657

1,533

1,740

4,179

Ordinary profit
Extraordinary income

Extraordinary losses

Profit before income taxes
Income taxes
ProfitProfit attributable to non-controlling interests
Profit attributable to owners of parent

109

129

1,631

4,049

Quarterly Consolidated Statements of comprehensive income(Millions of yen)

Prior Fiscal Year
(Mar. 1, 2022 – May 31 2022)

Current Fiscal Year
(Mar. 1, 2023 – May 31 2023)

1,740

4,179

Valuation difference on available-for-sale securities

(281)

1,391

Foreign currency translation adjustment

4,660

995

Remeasurements of defined benefit plans, net of tax

(80)

(46)

Share of other comprehensive income of entities accounted forusing equity method

(26)

(17)

Total other comprehensive income

4,272

2,322

6,012

6,501

5,928

6,320

84

181

ProfitOther comprehensive income

Comprehensive income
Comprehensive income attributable toComprehensive income attributable to owners of parent
Comprehensive income attributable to non-controlling interests